nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—breast cancer	0.482	1	CbGaD
Gatifloxacin—ALB—Irinotecan—breast cancer	0.0565	0.402	CbGbCtD
Gatifloxacin—ALB—Fluorouracil—breast cancer	0.0542	0.386	CbGbCtD
Gatifloxacin—ALB—Methotrexate—breast cancer	0.0299	0.213	CbGbCtD
Gatifloxacin—Moxifloxacin—TOP2A—breast cancer	0.00129	0.146	CrCbGaD
Gatifloxacin—Pefloxacin—TOP2A—breast cancer	0.000942	0.107	CrCbGaD
Gatifloxacin—Enoxacin—TOP2A—breast cancer	0.000881	0.0999	CrCbGaD
Gatifloxacin—Sparfloxacin—TOP2A—breast cancer	0.000811	0.0919	CrCbGaD
Gatifloxacin—Ofloxacin—ABCC1—breast cancer	0.00074	0.0838	CrCbGaD
Gatifloxacin—Lomefloxacin—TOP2A—breast cancer	0.000668	0.0757	CrCbGaD
Gatifloxacin—Ofloxacin—TOP2A—breast cancer	0.000571	0.0647	CrCbGaD
Gatifloxacin—Levofloxacin—TOP2A—breast cancer	0.000571	0.0647	CrCbGaD
Gatifloxacin—Ciprofloxacin—TOP2A—breast cancer	0.000551	0.0625	CrCbGaD
Gatifloxacin—Norfloxacin—TOP2A—breast cancer	0.000463	0.0525	CrCbGaD
Gatifloxacin—Norfloxacin—CYP1A1—breast cancer	0.000248	0.0281	CrCbGaD
Gatifloxacin—Sparfloxacin—ABCB1—breast cancer	0.000231	0.0261	CrCbGaD
Gatifloxacin—Levofloxacin—CYP3A4—breast cancer	0.000195	0.0221	CrCbGaD
Gatifloxacin—Ciprofloxacin—CYP3A4—breast cancer	0.000188	0.0213	CrCbGaD
Gatifloxacin—Levofloxacin—ABCB1—breast cancer	0.000162	0.0184	CrCbGaD
Gatifloxacin—Norfloxacin—CYP3A4—breast cancer	0.000158	0.0179	CrCbGaD
Gatifloxacin—Ciprofloxacin—ABCB1—breast cancer	0.000157	0.0178	CrCbGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CFL1—breast cancer	0.000103	0.00295	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—MTHFR—breast cancer	0.000102	0.00292	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—FN1—breast cancer	9.67e-05	0.00276	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—VEGFC—breast cancer	9.66e-05	0.00276	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—ALDOA—breast cancer	9.66e-05	0.00276	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—RAD51B—breast cancer	9.63e-05	0.00275	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—SERPINE1—breast cancer	9.39e-05	0.00268	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL1B—breast cancer	9.37e-05	0.00268	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—FN1—breast cancer	9.22e-05	0.00263	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—EGF—breast cancer	9.15e-05	0.00261	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC39A7—breast cancer	9.12e-05	0.0026	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—COX11—breast cancer	9.12e-05	0.0026	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—EGF—breast cancer	8.72e-05	0.00249	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IFNG—breast cancer	8.55e-05	0.00244	CbGpPWpGaD
Gatifloxacin—Hepatitis—Epirubicin—breast cancer	8.51e-05	0.000255	CcSEcCtD
Gatifloxacin—Eye disorder—Methotrexate—breast cancer	8.5e-05	0.000255	CcSEcCtD
Gatifloxacin—Diarrhoea—Fluorouracil—breast cancer	8.5e-05	0.000255	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Capecitabine—breast cancer	8.5e-05	0.000255	CcSEcCtD
Gatifloxacin—Tinnitus—Methotrexate—breast cancer	8.48e-05	0.000254	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—IGF1—breast cancer	8.48e-05	0.00242	CbGpPWpGaD
Gatifloxacin—Tachycardia—Capecitabine—breast cancer	8.47e-05	0.000254	CcSEcCtD
Gatifloxacin—Pharyngitis—Epirubicin—breast cancer	8.45e-05	0.000253	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	8.44e-05	0.00241	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—RELA—breast cancer	8.44e-05	0.00241	CbGpPWpGaD
Gatifloxacin—Sweating—Doxorubicin—breast cancer	8.41e-05	0.000252	CcSEcCtD
Gatifloxacin—Urticaria—Paclitaxel—breast cancer	8.4e-05	0.000252	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Capecitabine—breast cancer	8.39e-05	0.000252	CcSEcCtD
Gatifloxacin—Oedema peripheral—Epirubicin—breast cancer	8.39e-05	0.000251	CcSEcCtD
Gatifloxacin—Hypotension—Docetaxel—breast cancer	8.38e-05	0.000251	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—breast cancer	8.37e-05	0.000251	CcSEcCtD
Gatifloxacin—Abdominal pain—Paclitaxel—breast cancer	8.36e-05	0.000251	CcSEcCtD
Gatifloxacin—Body temperature increased—Paclitaxel—breast cancer	8.36e-05	0.000251	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC22A18—breast cancer	8.34e-05	0.00238	CbGpPWpGaD
Gatifloxacin—Epistaxis—Doxorubicin—breast cancer	8.28e-05	0.000248	CcSEcCtD
Gatifloxacin—Anorexia—Capecitabine—breast cancer	8.28e-05	0.000248	CcSEcCtD
Gatifloxacin—Vomiting—Irinotecan—breast cancer	8.25e-05	0.000247	CcSEcCtD
Gatifloxacin—Vomiting—Mitoxantrone—breast cancer	8.25e-05	0.000247	CcSEcCtD
Gatifloxacin—Dizziness—Fluorouracil—breast cancer	8.22e-05	0.000246	CcSEcCtD
Gatifloxacin—Visual impairment—Epirubicin—breast cancer	8.2e-05	0.000246	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—SERPINB2—breast cancer	8.19e-05	0.00234	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—RAD51C—breast cancer	8.19e-05	0.00234	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC2A2—breast cancer	8.18e-05	0.00234	CbGpPWpGaD
Gatifloxacin—Rash—Mitoxantrone—breast cancer	8.18e-05	0.000245	CcSEcCtD
Gatifloxacin—Rash—Irinotecan—breast cancer	8.18e-05	0.000245	CcSEcCtD
Gatifloxacin—Dermatitis—Irinotecan—breast cancer	8.17e-05	0.000245	CcSEcCtD
Gatifloxacin—Dermatitis—Mitoxantrone—breast cancer	8.17e-05	0.000245	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Docetaxel—breast cancer	8.17e-05	0.000245	CcSEcCtD
Gatifloxacin—Chills—Methotrexate—breast cancer	8.16e-05	0.000245	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TGFB2—breast cancer	8.14e-05	0.00232	CbGpPWpGaD
Gatifloxacin—Headache—Irinotecan—breast cancer	8.13e-05	0.000244	CcSEcCtD
Gatifloxacin—Headache—Mitoxantrone—breast cancer	8.13e-05	0.000244	CcSEcCtD
Gatifloxacin—Hypotension—Capecitabine—breast cancer	8.11e-05	0.000243	CcSEcCtD
Gatifloxacin—Insomnia—Docetaxel—breast cancer	8.11e-05	0.000243	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—THBS1—breast cancer	8.09e-05	0.00231	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—breast cancer	8.07e-05	0.00231	CbGpPWpGaD
Gatifloxacin—Paraesthesia—Docetaxel—breast cancer	8.05e-05	0.000241	CcSEcCtD
Gatifloxacin—Erythema multiforme—Epirubicin—breast cancer	8.05e-05	0.000241	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—SERPINE1—breast cancer	8.05e-05	0.0023	CbGpPWpGaD
Gatifloxacin—Vomiting—Gemcitabine—breast cancer	8.03e-05	0.000241	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLCO1B1—breast cancer	8.03e-05	0.00229	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC2A5—breast cancer	8.03e-05	0.00229	CbGpPWpGaD
Gatifloxacin—Bradycardia—Doxorubicin—breast cancer	8.02e-05	0.00024	CcSEcCtD
Gatifloxacin—Dyspnoea—Docetaxel—breast cancer	7.99e-05	0.00024	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—PDE2A—breast cancer	7.98e-05	0.00228	CbGpPWpGaD
Gatifloxacin—Somnolence—Docetaxel—breast cancer	7.97e-05	0.000239	CcSEcCtD
Gatifloxacin—Rash—Gemcitabine—breast cancer	7.97e-05	0.000239	CcSEcCtD
Gatifloxacin—Dermatitis—Gemcitabine—breast cancer	7.96e-05	0.000239	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—breast cancer	7.96e-05	0.000239	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—breast cancer	7.94e-05	0.000238	CcSEcCtD
Gatifloxacin—Erythema—Methotrexate—breast cancer	7.92e-05	0.000237	CcSEcCtD
Gatifloxacin—Headache—Gemcitabine—breast cancer	7.92e-05	0.000237	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Capecitabine—breast cancer	7.91e-05	0.000237	CcSEcCtD
Gatifloxacin—Vomiting—Fluorouracil—breast cancer	7.9e-05	0.000237	CcSEcCtD
Gatifloxacin—Dyspepsia—Docetaxel—breast cancer	7.89e-05	0.000237	CcSEcCtD
Gatifloxacin—Hepatitis—Doxorubicin—breast cancer	7.88e-05	0.000236	CcSEcCtD
Gatifloxacin—Insomnia—Capecitabine—breast cancer	7.85e-05	0.000235	CcSEcCtD
Gatifloxacin—Rash—Fluorouracil—breast cancer	7.83e-05	0.000235	CcSEcCtD
Gatifloxacin—Dermatitis—Fluorouracil—breast cancer	7.83e-05	0.000235	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—breast cancer	7.82e-05	0.000234	CcSEcCtD
Gatifloxacin—Paraesthesia—Capecitabine—breast cancer	7.8e-05	0.000234	CcSEcCtD
Gatifloxacin—Decreased appetite—Docetaxel—breast cancer	7.8e-05	0.000234	CcSEcCtD
Gatifloxacin—Hypersensitivity—Paclitaxel—breast cancer	7.79e-05	0.000234	CcSEcCtD
Gatifloxacin—Headache—Fluorouracil—breast cancer	7.78e-05	0.000233	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—breast cancer	7.76e-05	0.000233	CcSEcCtD
Gatifloxacin—Dysgeusia—Methotrexate—breast cancer	7.75e-05	0.000233	CcSEcCtD
Gatifloxacin—Dyspnoea—Capecitabine—breast cancer	7.74e-05	0.000232	CcSEcCtD
Gatifloxacin—Nausea—Mitoxantrone—breast cancer	7.71e-05	0.000231	CcSEcCtD
Gatifloxacin—Nausea—Irinotecan—breast cancer	7.71e-05	0.000231	CcSEcCtD
Gatifloxacin—Constipation—Docetaxel—breast cancer	7.67e-05	0.00023	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—breast cancer	7.67e-05	0.00219	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	7.67e-05	0.00219	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	7.67e-05	0.00219	CbGpPWpGaD
Gatifloxacin—Back pain—Methotrexate—breast cancer	7.66e-05	0.00023	CcSEcCtD
Gatifloxacin—Dyspepsia—Capecitabine—breast cancer	7.64e-05	0.000229	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—breast cancer	7.64e-05	0.000229	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—IL1B—breast cancer	7.63e-05	0.00218	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—KDM1A—breast cancer	7.62e-05	0.00217	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL2—breast cancer	7.6e-05	0.00217	CbGpPWpGaD
Gatifloxacin—Visual impairment—Doxorubicin—breast cancer	7.59e-05	0.000228	CcSEcCtD
Gatifloxacin—Asthenia—Paclitaxel—breast cancer	7.59e-05	0.000228	CcSEcCtD
Gatifloxacin—Decreased appetite—Capecitabine—breast cancer	7.55e-05	0.000226	CcSEcCtD
Gatifloxacin—Nausea—Gemcitabine—breast cancer	7.51e-05	0.000225	CcSEcCtD
Gatifloxacin—Pruritus—Paclitaxel—breast cancer	7.48e-05	0.000224	CcSEcCtD
Gatifloxacin—Vision blurred—Methotrexate—breast cancer	7.46e-05	0.000224	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—SERPINE1—breast cancer	7.46e-05	0.00213	CbGpPWpGaD
Gatifloxacin—Erythema multiforme—Doxorubicin—breast cancer	7.45e-05	0.000223	CcSEcCtD
Gatifloxacin—Constipation—Capecitabine—breast cancer	7.42e-05	0.000223	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—breast cancer	7.41e-05	0.000222	CcSEcCtD
Gatifloxacin—Feeling abnormal—Docetaxel—breast cancer	7.39e-05	0.000222	CcSEcCtD
Gatifloxacin—Nausea—Fluorouracil—breast cancer	7.38e-05	0.000221	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—breast cancer	7.36e-05	0.000221	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—breast cancer	7.34e-05	0.00022	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Docetaxel—breast cancer	7.33e-05	0.00022	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—breast cancer	7.3e-05	0.000219	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—STIM1—breast cancer	7.3e-05	0.00208	CbGpPWpGaD
Gatifloxacin—Tension—Epirubicin—breast cancer	7.27e-05	0.000218	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HADHB—breast cancer	7.27e-05	0.00208	CbGpPWpGaD
Gatifloxacin—Dysgeusia—Epirubicin—breast cancer	7.26e-05	0.000218	CcSEcCtD
Gatifloxacin—Diarrhoea—Paclitaxel—breast cancer	7.24e-05	0.000217	CcSEcCtD
Gatifloxacin—Nervousness—Epirubicin—breast cancer	7.2e-05	0.000216	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—breast cancer	7.17e-05	0.000215	CcSEcCtD
Gatifloxacin—Feeling abnormal—Capecitabine—breast cancer	7.15e-05	0.000215	CcSEcCtD
Gatifloxacin—Muscle spasms—Epirubicin—breast cancer	7.13e-05	0.000214	CcSEcCtD
Gatifloxacin—Vertigo—Methotrexate—breast cancer	7.11e-05	0.000213	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Capecitabine—breast cancer	7.1e-05	0.000213	CcSEcCtD
Gatifloxacin—Abdominal pain—Docetaxel—breast cancer	7.09e-05	0.000213	CcSEcCtD
Gatifloxacin—Body temperature increased—Docetaxel—breast cancer	7.09e-05	0.000213	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—breast cancer	7.07e-05	0.000212	CcSEcCtD
Gatifloxacin—Dizziness—Paclitaxel—breast cancer	7e-05	0.00021	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—breast cancer	6.98e-05	0.000209	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC39A6—breast cancer	6.91e-05	0.00197	CbGpPWpGaD
Gatifloxacin—Urticaria—Capecitabine—breast cancer	6.9e-05	0.000207	CcSEcCtD
Gatifloxacin—Body temperature increased—Capecitabine—breast cancer	6.86e-05	0.000206	CcSEcCtD
Gatifloxacin—Abdominal pain—Capecitabine—breast cancer	6.86e-05	0.000206	CcSEcCtD
Gatifloxacin—Convulsion—Methotrexate—breast cancer	6.86e-05	0.000206	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—breast cancer	6.86e-05	0.000206	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—breast cancer	6.81e-05	0.000204	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—TNF—breast cancer	6.8e-05	0.00194	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IFNG—breast cancer	6.79e-05	0.00194	CbGpPWpGaD
Gatifloxacin—Flatulence—Doxorubicin—breast cancer	6.76e-05	0.000203	CcSEcCtD
Gatifloxacin—Arthralgia—Methotrexate—breast cancer	6.74e-05	0.000202	CcSEcCtD
Gatifloxacin—Myalgia—Methotrexate—breast cancer	6.74e-05	0.000202	CcSEcCtD
Gatifloxacin—Chest pain—Methotrexate—breast cancer	6.74e-05	0.000202	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—breast cancer	6.73e-05	0.000202	CcSEcCtD
Gatifloxacin—Vomiting—Paclitaxel—breast cancer	6.73e-05	0.000202	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—breast cancer	6.72e-05	0.000201	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—RELA—breast cancer	6.7e-05	0.00191	CbGpPWpGaD
Gatifloxacin—Rash—Paclitaxel—breast cancer	6.67e-05	0.0002	CcSEcCtD
Gatifloxacin—Dermatitis—Paclitaxel—breast cancer	6.66e-05	0.0002	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—breast cancer	6.66e-05	0.0002	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—breast cancer	6.66e-05	0.0002	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—FHL2—breast cancer	6.65e-05	0.0019	CbGpPWpGaD
Gatifloxacin—Syncope—Epirubicin—breast cancer	6.65e-05	0.000199	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—breast cancer	6.63e-05	0.000199	CcSEcCtD
Gatifloxacin—Headache—Paclitaxel—breast cancer	6.63e-05	0.000199	CcSEcCtD
Gatifloxacin—Hypersensitivity—Docetaxel—breast cancer	6.61e-05	0.000198	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—breast cancer	6.59e-05	0.000198	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC5A5—breast cancer	6.56e-05	0.00187	CbGpPWpGaD
Gatifloxacin—Palpitations—Epirubicin—breast cancer	6.55e-05	0.000196	CcSEcCtD
Gatifloxacin—Confusional state—Methotrexate—breast cancer	6.52e-05	0.000195	CcSEcCtD
Gatifloxacin—Loss of consciousness—Epirubicin—breast cancer	6.51e-05	0.000195	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—PTGS2—breast cancer	6.51e-05	0.00186	CbGpPWpGaD
Gatifloxacin—Anaphylactic shock—Methotrexate—breast cancer	6.46e-05	0.000194	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—breast cancer	6.46e-05	0.000194	CcSEcCtD
Gatifloxacin—Asthenia—Docetaxel—breast cancer	6.43e-05	0.000193	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PLG—breast cancer	6.43e-05	0.00184	CbGpPWpGaD
Gatifloxacin—Convulsion—Epirubicin—breast cancer	6.42e-05	0.000193	CcSEcCtD
Gatifloxacin—Infection—Methotrexate—breast cancer	6.42e-05	0.000193	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—breast cancer	6.4e-05	0.000192	CcSEcCtD
Gatifloxacin—Hypersensitivity—Capecitabine—breast cancer	6.4e-05	0.000192	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—F3—breast cancer	6.38e-05	0.00182	CbGpPWpGaD
Gatifloxacin—Pruritus—Docetaxel—breast cancer	6.34e-05	0.00019	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC2A1—breast cancer	6.34e-05	0.00181	CbGpPWpGaD
Gatifloxacin—Thrombocytopenia—Methotrexate—breast cancer	6.33e-05	0.00019	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ATP7B—breast cancer	6.32e-05	0.0018	CbGpPWpGaD
Gatifloxacin—Chest pain—Epirubicin—breast cancer	6.31e-05	0.000189	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—breast cancer	6.31e-05	0.000189	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—breast cancer	6.31e-05	0.000189	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—breast cancer	6.3e-05	0.000189	CcSEcCtD
Gatifloxacin—Anxiety—Epirubicin—breast cancer	6.29e-05	0.000189	CcSEcCtD
Gatifloxacin—Nausea—Paclitaxel—breast cancer	6.28e-05	0.000188	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Methotrexate—breast cancer	6.25e-05	0.000187	CcSEcCtD
Gatifloxacin—Asthenia—Capecitabine—breast cancer	6.23e-05	0.000187	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	6.18e-05	0.00176	CbGpPWpGaD
Gatifloxacin—Vertigo—Doxorubicin—breast cancer	6.16e-05	0.000185	CcSEcCtD
Gatifloxacin—Anorexia—Methotrexate—breast cancer	6.16e-05	0.000185	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—breast cancer	6.15e-05	0.000184	CcSEcCtD
Gatifloxacin—Pruritus—Capecitabine—breast cancer	6.14e-05	0.000184	CcSEcCtD
Gatifloxacin—Diarrhoea—Docetaxel—breast cancer	6.14e-05	0.000184	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PDGFA—breast cancer	6.1e-05	0.00174	CbGpPWpGaD
Gatifloxacin—Confusional state—Epirubicin—breast cancer	6.1e-05	0.000183	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—breast cancer	6.06e-05	0.000182	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL1B—breast cancer	6.06e-05	0.00173	CbGpPWpGaD
Gatifloxacin—Oedema—Epirubicin—breast cancer	6.05e-05	0.000181	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—breast cancer	6.05e-05	0.000181	CcSEcCtD
Gatifloxacin—Hypotension—Methotrexate—breast cancer	6.04e-05	0.000181	CcSEcCtD
Gatifloxacin—Loss of consciousness—Doxorubicin—breast cancer	6.03e-05	0.000181	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—breast cancer	6.01e-05	0.00018	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	5.98e-05	0.00171	CbGpPWpGaD
Gatifloxacin—Shock—Epirubicin—breast cancer	5.95e-05	0.000178	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—breast cancer	5.94e-05	0.000178	CcSEcCtD
Gatifloxacin—Diarrhoea—Capecitabine—breast cancer	5.94e-05	0.000178	CcSEcCtD
Gatifloxacin—Dizziness—Docetaxel—breast cancer	5.93e-05	0.000178	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—breast cancer	5.92e-05	0.000178	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—ITPR1—breast cancer	5.92e-05	0.00169	CbGpPWpGaD
Gatifloxacin—Hypertension—Doxorubicin—breast cancer	5.92e-05	0.000178	CcSEcCtD
Gatifloxacin—Tachycardia—Epirubicin—breast cancer	5.9e-05	0.000177	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Methotrexate—breast cancer	5.89e-05	0.000177	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCC1—breast cancer	5.88e-05	0.00168	CbGpPWpGaD
Gatifloxacin—Hyperhidrosis—Epirubicin—breast cancer	5.85e-05	0.000175	CcSEcCtD
Gatifloxacin—Insomnia—Methotrexate—breast cancer	5.85e-05	0.000175	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—breast cancer	5.84e-05	0.000175	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—breast cancer	5.84e-05	0.000175	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—breast cancer	5.84e-05	0.000175	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—breast cancer	5.82e-05	0.000174	CcSEcCtD
Gatifloxacin—Paraesthesia—Methotrexate—breast cancer	5.8e-05	0.000174	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—breast cancer	5.77e-05	0.000173	CcSEcCtD
Gatifloxacin—Dyspnoea—Methotrexate—breast cancer	5.76e-05	0.000173	CcSEcCtD
Gatifloxacin—Somnolence—Methotrexate—breast cancer	5.75e-05	0.000172	CcSEcCtD
Gatifloxacin—Dizziness—Capecitabine—breast cancer	5.74e-05	0.000172	CcSEcCtD
Gatifloxacin—Vomiting—Docetaxel—breast cancer	5.7e-05	0.000171	CcSEcCtD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	5.7e-05	0.00163	CbGpPWpGaD
Gatifloxacin—Dyspepsia—Methotrexate—breast cancer	5.69e-05	0.000171	CcSEcCtD
Gatifloxacin—Rash—Docetaxel—breast cancer	5.65e-05	0.00017	CcSEcCtD
Gatifloxacin—Hypotension—Epirubicin—breast cancer	5.65e-05	0.000169	CcSEcCtD
Gatifloxacin—Dermatitis—Docetaxel—breast cancer	5.65e-05	0.000169	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—breast cancer	5.64e-05	0.000169	CcSEcCtD
Gatifloxacin—Decreased appetite—Methotrexate—breast cancer	5.62e-05	0.000168	CcSEcCtD
Gatifloxacin—Headache—Docetaxel—breast cancer	5.62e-05	0.000168	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—breast cancer	5.6e-05	0.000168	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—breast cancer	5.6e-05	0.000168	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—breast cancer	5.56e-05	0.000167	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—VEGFA—breast cancer	5.54e-05	0.00158	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—TNF—breast cancer	5.53e-05	0.00158	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PLA2G4A—breast cancer	5.53e-05	0.00158	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—HGF—breast cancer	5.53e-05	0.00158	CbGpPWpGaD
Gatifloxacin—Vomiting—Capecitabine—breast cancer	5.52e-05	0.000166	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—breast cancer	5.51e-05	0.000165	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPX2—breast cancer	5.51e-05	0.00157	CbGpPWpGaD
Gatifloxacin—Shock—Doxorubicin—breast cancer	5.51e-05	0.000165	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL6—breast cancer	5.49e-05	0.00157	CbGpPWpGaD
Gatifloxacin—Thrombocytopenia—Doxorubicin—breast cancer	5.48e-05	0.000164	CcSEcCtD
Gatifloxacin—Rash—Capecitabine—breast cancer	5.47e-05	0.000164	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—breast cancer	5.47e-05	0.000164	CcSEcCtD
Gatifloxacin—Dermatitis—Capecitabine—breast cancer	5.47e-05	0.000164	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CSF2—breast cancer	5.47e-05	0.00156	CbGpPWpGaD
Gatifloxacin—Tachycardia—Doxorubicin—breast cancer	5.46e-05	0.000164	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPX4—breast cancer	5.44e-05	0.00155	CbGpPWpGaD
Gatifloxacin—Headache—Capecitabine—breast cancer	5.44e-05	0.000163	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—breast cancer	5.43e-05	0.000163	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—breast cancer	5.41e-05	0.000162	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—breast cancer	5.39e-05	0.000162	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—breast cancer	5.38e-05	0.000161	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—breast cancer	5.33e-05	0.00016	CcSEcCtD
Gatifloxacin—Nausea—Docetaxel—breast cancer	5.33e-05	0.00016	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—CFL1—breast cancer	5.33e-05	0.00152	CbGpPWpGaD
Gatifloxacin—Feeling abnormal—Methotrexate—breast cancer	5.33e-05	0.00016	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—breast cancer	5.32e-05	0.00016	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—IDH1—breast cancer	5.31e-05	0.00152	CbGpPWpGaD
Gatifloxacin—Gastrointestinal pain—Methotrexate—breast cancer	5.28e-05	0.000158	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—GRB7—breast cancer	5.28e-05	0.00151	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—breast cancer	5.27e-05	0.00151	CbGpPWpGaD
Gatifloxacin—Decreased appetite—Epirubicin—breast cancer	5.26e-05	0.000158	CcSEcCtD
Gatifloxacin—Hypotension—Doxorubicin—breast cancer	5.23e-05	0.000157	CcSEcCtD
Gatifloxacin—Constipation—Epirubicin—breast cancer	5.17e-05	0.000155	CcSEcCtD
Gatifloxacin—Nausea—Capecitabine—breast cancer	5.16e-05	0.000155	CcSEcCtD
Gatifloxacin—ALB—Metabolism—SYNJ2—breast cancer	5.15e-05	0.00147	CbGpPWpGaD
Gatifloxacin—Urticaria—Methotrexate—breast cancer	5.13e-05	0.000154	CcSEcCtD
Gatifloxacin—Abdominal pain—Methotrexate—breast cancer	5.11e-05	0.000153	CcSEcCtD
Gatifloxacin—Body temperature increased—Methotrexate—breast cancer	5.11e-05	0.000153	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.1e-05	0.000153	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—TGFB1—breast cancer	5.08e-05	0.00145	CbGpPWpGaD
Gatifloxacin—Insomnia—Doxorubicin—breast cancer	5.06e-05	0.000152	CcSEcCtD
Gatifloxacin—Paraesthesia—Doxorubicin—breast cancer	5.03e-05	0.000151	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—TUBB3—breast cancer	5e-05	0.00143	CbGpPWpGaD
Gatifloxacin—Dyspnoea—Doxorubicin—breast cancer	4.99e-05	0.00015	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—breast cancer	4.98e-05	0.000149	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—VEGFC—breast cancer	4.98e-05	0.00142	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ALDOA—breast cancer	4.98e-05	0.00142	CbGpPWpGaD
Gatifloxacin—Somnolence—Doxorubicin—breast cancer	4.98e-05	0.000149	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—breast cancer	4.95e-05	0.000148	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—breast cancer	4.93e-05	0.000148	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—TP53—breast cancer	4.88e-05	0.00139	CbGpPWpGaD
Gatifloxacin—Decreased appetite—Doxorubicin—breast cancer	4.86e-05	0.000146	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—breast cancer	4.84e-05	0.00138	CbGpPWpGaD
Gatifloxacin—Urticaria—Epirubicin—breast cancer	4.8e-05	0.000144	CcSEcCtD
Gatifloxacin—ALB—Metabolism—NDUFS3—breast cancer	4.79e-05	0.00137	CbGpPWpGaD
Gatifloxacin—Constipation—Doxorubicin—breast cancer	4.79e-05	0.000144	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—breast cancer	4.78e-05	0.000143	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—breast cancer	4.78e-05	0.000143	CcSEcCtD
Gatifloxacin—Hypersensitivity—Methotrexate—breast cancer	4.76e-05	0.000143	CcSEcCtD
Gatifloxacin—Asthenia—Methotrexate—breast cancer	4.64e-05	0.000139	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—breast cancer	4.61e-05	0.000138	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—MED12—breast cancer	4.61e-05	0.00132	CbGpPWpGaD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—breast cancer	4.58e-05	0.000137	CcSEcCtD
Gatifloxacin—Pruritus—Methotrexate—breast cancer	4.57e-05	0.000137	CcSEcCtD
Gatifloxacin—ALB—Metabolism—CHST9—breast cancer	4.5e-05	0.00129	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL6—breast cancer	4.47e-05	0.00128	CbGpPWpGaD
Gatifloxacin—Hypersensitivity—Epirubicin—breast cancer	4.46e-05	0.000134	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—breast cancer	4.45e-05	0.000133	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—breast cancer	4.42e-05	0.000133	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—breast cancer	4.42e-05	0.000133	CcSEcCtD
Gatifloxacin—Diarrhoea—Methotrexate—breast cancer	4.42e-05	0.000133	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	4.4e-05	0.00126	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—TNF—breast cancer	4.4e-05	0.00126	CbGpPWpGaD
Gatifloxacin—Asthenia—Epirubicin—breast cancer	4.34e-05	0.00013	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—FN1—breast cancer	4.29e-05	0.00123	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	4.28e-05	0.00122	CbGpPWpGaD
Gatifloxacin—Pruritus—Epirubicin—breast cancer	4.28e-05	0.000128	CcSEcCtD
Gatifloxacin—Dizziness—Methotrexate—breast cancer	4.27e-05	0.000128	CcSEcCtD
Gatifloxacin—ALB—Metabolism—COX11—breast cancer	4.27e-05	0.00122	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	4.2e-05	0.0012	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TGFB2—breast cancer	4.19e-05	0.0012	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—THBS1—breast cancer	4.17e-05	0.00119	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC2A2—breast cancer	4.16e-05	0.00119	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Epirubicin—breast cancer	4.14e-05	0.000124	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—breast cancer	4.12e-05	0.000124	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—GATA3—breast cancer	4.11e-05	0.00117	CbGpPWpGaD
Gatifloxacin—Vomiting—Methotrexate—breast cancer	4.11e-05	0.000123	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CG—breast cancer	4.11e-05	0.00117	CbGpPWpGaD
Gatifloxacin—Rash—Methotrexate—breast cancer	4.08e-05	0.000122	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ACHE—breast cancer	4.07e-05	0.00116	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCG2—breast cancer	4.07e-05	0.00116	CbGpPWpGaD
Gatifloxacin—Dermatitis—Methotrexate—breast cancer	4.07e-05	0.000122	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—EGF—breast cancer	4.06e-05	0.00116	CbGpPWpGaD
Gatifloxacin—Headache—Methotrexate—breast cancer	4.05e-05	0.000121	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—breast cancer	4.02e-05	0.00012	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—breast cancer	4e-05	0.00012	CcSEcCtD
Gatifloxacin—Pruritus—Doxorubicin—breast cancer	3.96e-05	0.000119	CcSEcCtD
Gatifloxacin—ALB—Metabolism—SHMT1—breast cancer	3.91e-05	0.00112	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CDA—breast cancer	3.91e-05	0.00112	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.86e-05	0.0011	CbGpPWpGaD
Gatifloxacin—Vomiting—Epirubicin—breast cancer	3.85e-05	0.000115	CcSEcCtD
Gatifloxacin—Nausea—Methotrexate—breast cancer	3.84e-05	0.000115	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—breast cancer	3.83e-05	0.000115	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.82e-05	0.00109	CbGpPWpGaD
Gatifloxacin—Rash—Epirubicin—breast cancer	3.81e-05	0.000114	CcSEcCtD
Gatifloxacin—Dermatitis—Epirubicin—breast cancer	3.81e-05	0.000114	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—breast cancer	3.79e-05	0.000114	CcSEcCtD
Gatifloxacin—ALB—Metabolism—SLCO1B1—breast cancer	3.76e-05	0.00107	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC2A5—breast cancer	3.76e-05	0.00107	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IGF1—breast cancer	3.76e-05	0.00107	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—AKT2—breast cancer	3.76e-05	0.00107	CbGpPWpGaD
Gatifloxacin—Dizziness—Doxorubicin—breast cancer	3.7e-05	0.000111	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—IFNB1—breast cancer	3.69e-05	0.00105	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.67e-05	0.00105	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APRT—breast cancer	3.63e-05	0.00104	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—TFRC—breast cancer	3.63e-05	0.00104	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CD—breast cancer	3.61e-05	0.00103	CbGpPWpGaD
Gatifloxacin—Nausea—Epirubicin—breast cancer	3.59e-05	0.000108	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SERPINE1—breast cancer	3.57e-05	0.00102	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.56e-05	0.00102	CbGpPWpGaD
Gatifloxacin—Vomiting—Doxorubicin—breast cancer	3.56e-05	0.000107	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.55e-05	0.00101	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL6—breast cancer	3.55e-05	0.00101	CbGpPWpGaD
Gatifloxacin—Rash—Doxorubicin—breast cancer	3.53e-05	0.000106	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—breast cancer	3.53e-05	0.000106	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—breast cancer	3.51e-05	0.000105	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—NCOA2—breast cancer	3.49e-05	0.000998	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ESRRA—breast cancer	3.41e-05	0.000975	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ANGPTL4—breast cancer	3.41e-05	0.000975	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAUR—breast cancer	3.39e-05	0.000969	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.33e-05	0.000952	CbGpPWpGaD
Gatifloxacin—Nausea—Doxorubicin—breast cancer	3.32e-05	9.97e-05	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—PLG—breast cancer	3.31e-05	0.000947	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	3.25e-05	0.000927	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPI—breast cancer	3.24e-05	0.000924	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HADHB—breast cancer	3.24e-05	0.000924	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—RAF1—breast cancer	3.22e-05	0.00092	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.22e-05	0.000919	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PDGFA—breast cancer	3.15e-05	0.000899	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CB—breast cancer	3.15e-05	0.000899	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	3.1e-05	0.000884	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ALDH7A1—breast cancer	3.09e-05	0.000882	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ALDH1A1—breast cancer	3.09e-05	0.000882	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ITPR1—breast cancer	3.05e-05	0.000872	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	3.05e-05	0.000872	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ABL1—breast cancer	3.03e-05	0.000866	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—FHL2—breast cancer	2.96e-05	0.000845	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NME1—breast cancer	2.96e-05	0.000845	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—UMPS—breast cancer	2.96e-05	0.000845	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PHGDH—breast cancer	2.96e-05	0.000845	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ADSL—breast cancer	2.96e-05	0.000845	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—NCOA1—breast cancer	2.94e-05	0.000841	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HPSE—breast cancer	2.9e-05	0.000829	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LDHB—breast cancer	2.9e-05	0.000829	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—BRIP1—breast cancer	2.9e-05	0.000829	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IL2—breast cancer	2.89e-05	0.000825	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—PLG—breast cancer	2.87e-05	0.000819	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLA2G4A—breast cancer	2.85e-05	0.000814	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—HGF—breast cancer	2.85e-05	0.000814	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CSF2—breast cancer	2.82e-05	0.000805	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTA3—breast cancer	2.75e-05	0.000786	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HMMR—breast cancer	2.75e-05	0.000786	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCC1—breast cancer	2.75e-05	0.000786	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPARGC1B—breast cancer	2.67e-05	0.000761	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—HMOX1—breast cancer	2.65e-05	0.000756	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.6e-05	0.000741	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.6e-05	0.000741	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCB1—breast cancer	2.54e-05	0.000726	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SRC—breast cancer	2.52e-05	0.00072	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CA9—breast cancer	2.52e-05	0.000719	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTA4—breast cancer	2.52e-05	0.000719	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.49e-05	0.00071	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.46e-05	0.000703	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—VEGFA—breast cancer	2.46e-05	0.000701	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTA2—breast cancer	2.45e-05	0.0007	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPX2—breast cancer	2.45e-05	0.0007	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MMP1—breast cancer	2.42e-05	0.000692	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPX4—breast cancer	2.42e-05	0.000692	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SULT1A1—breast cancer	2.42e-05	0.000692	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAU—breast cancer	2.38e-05	0.000679	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CDK2—breast cancer	2.38e-05	0.000679	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—IDH1—breast cancer	2.37e-05	0.000676	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTA1—breast cancer	2.37e-05	0.000676	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NAT2—breast cancer	2.34e-05	0.000668	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CAV1—breast cancer	2.32e-05	0.000664	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	2.32e-05	0.000663	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	2.25e-05	0.000644	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—FN1—breast cancer	2.21e-05	0.000632	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS2—breast cancer	2.19e-05	0.000624	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CG—breast cancer	2.12e-05	0.000604	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.12e-05	0.000604	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—EGF—breast cancer	2.09e-05	0.000597	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MED12—breast cancer	2.05e-05	0.000586	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—DPYD—breast cancer	2.05e-05	0.000586	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ALDOA—breast cancer	2.02e-05	0.000577	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOA3—breast cancer	1.96e-05	0.00056	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC2A2—breast cancer	1.95e-05	0.000556	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IGF1—breast cancer	1.94e-05	0.000553	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—AKT2—breast cancer	1.94e-05	0.000553	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.93e-05	0.00055	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	1.92e-05	0.000548	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CPT1A—breast cancer	1.91e-05	0.000545	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCG2—breast cancer	1.91e-05	0.000545	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTR—breast cancer	1.91e-05	0.000545	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HPGDS—breast cancer	1.87e-05	0.000534	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CD—breast cancer	1.86e-05	0.000531	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HBA1—breast cancer	1.86e-05	0.000531	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SERPINE1—breast cancer	1.84e-05	0.000526	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTT1—breast cancer	1.81e-05	0.000518	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ACHE—breast cancer	1.81e-05	0.000518	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS3—breast cancer	1.76e-05	0.000502	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP17A1—breast cancer	1.72e-05	0.00049	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ENO1—breast cancer	1.7e-05	0.000486	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTGS1—breast cancer	1.7e-05	0.000486	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.69e-05	0.000484	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP2D6—breast cancer	1.67e-05	0.000476	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—RAF1—breast cancer	1.66e-05	0.000474	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOA2—breast cancer	1.64e-05	0.000467	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CB—breast cancer	1.62e-05	0.000463	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—FASN—breast cancer	1.59e-05	0.000453	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—BCHE—breast cancer	1.58e-05	0.000451	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	1.57e-05	0.000447	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC5A5—breast cancer	1.56e-05	0.000446	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC2A1—breast cancer	1.51e-05	0.000431	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NQO1—breast cancer	1.51e-05	0.000431	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IL2—breast cancer	1.49e-05	0.000425	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.48e-05	0.000422	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP3A4—breast cancer	1.47e-05	0.00042	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.46e-05	0.000418	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP1B1—breast cancer	1.45e-05	0.000413	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	1.44e-05	0.000411	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSP90AA1—breast cancer	1.42e-05	0.000405	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOA1—breast cancer	1.38e-05	0.000394	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—STK11—breast cancer	1.36e-05	0.000388	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP19A1—breast cancer	1.36e-05	0.000388	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SRC—breast cancer	1.3e-05	0.000371	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.28e-05	0.000364	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—VEGFA—breast cancer	1.27e-05	0.000361	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—COMT—breast cancer	1.26e-05	0.000361	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTP1—breast cancer	1.26e-05	0.000359	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HMOX1—breast cancer	1.24e-05	0.000354	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ITPR1—breast cancer	1.24e-05	0.000353	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MAPK3—breast cancer	1.2e-05	0.000342	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCB1—breast cancer	1.19e-05	0.00034	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TYMS—breast cancer	1.17e-05	0.000334	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TGFB1—breast cancer	1.16e-05	0.000332	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTM1—breast cancer	1.16e-05	0.00033	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOR1—breast cancer	1.16e-05	0.00033	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLA2G4A—breast cancer	1.16e-05	0.00033	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPX1—breast cancer	1.11e-05	0.000316	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP1A1—breast cancer	1.1e-05	0.000313	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ERCC2—breast cancer	1.09e-05	0.00031	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—KRAS—breast cancer	1.08e-05	0.000307	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTHFR—breast cancer	1.02e-05	0.000292	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CA—breast cancer	9.89e-06	0.000282	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TP53—breast cancer	9.56e-06	0.000273	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CAV1—breast cancer	9.42e-06	0.000269	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—HRAS—breast cancer	9.15e-06	0.000261	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9e-06	0.000257	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CG—breast cancer	8.58e-06	0.000245	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—AKT1—breast cancer	8.08e-06	0.000231	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CD—breast cancer	7.54e-06	0.000215	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NOS3—breast cancer	7.12e-06	0.000203	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CB—breast cancer	6.58e-06	0.000188	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTGS2—breast cancer	6.52e-06	0.000186	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTEN—breast cancer	5.68e-06	0.000162	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CA—breast cancer	4.01e-06	0.000114	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AKT1—breast cancer	3.27e-06	9.35e-05	CbGpPWpGaD
